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Abstract. 
 
We expressed the human anti-apoptotic pro-
tein, Bcl-2, in 
 
Saccharomyces cerevisiae
 
 to investigate 
its effects on antioxidant protection and stationary 
phase survival. Yeast lacking copper-zinc superoxide 
 
dismutase (
 
sod1
 
D
 
) show a profound defect in entry 
into and survival during stationary phase even under 
conditions optimal for survival of wild-type strains (in-
cubation in water after stationary phase is reached). 
Expression of Bcl-2 in the 
 
sod1
 
D
 
 strain caused a large 
improvement in viability at entry into stationary phase, 
as well as increased resistance to 100% oxygen and in-
creased catalase activity. In addition, Bcl-2 expression 
reduced mutation frequency in both wild-type and 
 
sod1
 
D
 
 strains. In another set of experiments, wild-type 
yeast incubated in expired minimal medium instead of 
water lost viability quickly; expression of Bcl-2 signifi-
cantly delayed this stationary phase death. Our results 
demonstrate that Bcl-2 has activities in yeast that are 
similar to activities it is known to possess in mammalian 
cells: (
 
a
 
) stimulation of antioxidant protection and (
 
b
 
) 
delay of processes leading to cell death.
B
 
cl
 
-2 is a human protein that was originally isolated
based on its oncogenic properties (37). Unlike
most carcinogens, which act by affecting cell pro-
liferation, Bcl-2 acts by inhibiting cell death, but the pre-
cise mechanism of its action is unknown. Bcl-2 does ap-
pear to play an antioxidant role in some experimental
systems, possibly by blocking the generation of oxygen
radical species that play a role in apoptotic or necrotic pro-
cesses (16).
Apoptosis is a type of programmed cell death, or cell
suicide, in which a clearly defined and active pathway
leads to an orderly death. Apoptosis has defining morpho-
logic features in mammalian cells, but programmed cell
death without some or all of these features occurs in some
lower organisms (4, 28, 31).
Oxidative damage can cause cell death by either apopto-
sis or necrosis, depending on the degree of the damage.
Expression of Bcl-2 in neuronal cells has been shown to
result in decreased generation of reactive oxygen species,
decreased lipid peroxidation, and decreased apoptosis
(19). It has also been shown that Bcl-2 can inhibit necrotic
death (death by catastrophe, which includes cell lysis and
uncontrolled spillage of contents), as well as apoptotic
death in mammalian neuronal cells (20). Bcl-2 was found
to protect mammalian cells from death due to other oxida-
tive insults as well, such as hypoxia/glycemia, ionizing radi-
ation, and hydrogen peroxide (16, 32). On the other hand,
it has recently been shown that Bcl-2 can inhibit oxygen-
independent apoptosis (18, 33), suggesting that it can also
act in a paradigm that does not require oxygen.
The yeast 
 
Saccharomyces cerevisiae
 
 is a highly studied
unicellular eucaryote with some remarkable similarities to
human cells at the macromolecular and organelle level. A
number of yeast proteins, such as Ras (27) and superoxide
dismutase (29), have been shown to be functionally inter-
changeable with the highly homologous human proteins.
Furthermore, yeast can be easily manipulated genetically
(12) and its genome has been completely sequenced (26);
these features make this simple eukaryote an excellent
host for study of the function of human proteins.
Yeast, like other eukaryotic cells, contain two unrelated
superoxide dismutases (SODs):
 
1
 
 a copper- and zinc-con-
taining form (CuZnSOD, product of the 
 
SOD1
 
 gene) in
the cytoplasm and a less abundant manganese containing
form (MnSOD, product of the 
 
SOD2
 
 gene) in the mito-
chondrial matrix. Yeast mutants lacking CuZnSOD (
 
sod1
 
D
 
)
are in a chronic state of oxidative stress while they are
growing in air, are sensitive to hyperoxia, and are unable
to grow in the absence of methionine and lysine (8). Yeast
mutants lacking MnSOD (
 
sod2
 
D
 
) have a less dramatic
phenotype when grown in standard glucose media, but are
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sensitive to hyperoxia. The phenotype of the double mu-
tant (
 
sod1
 
D
 
sod2
 
D
 
) is a summation of the single mutant
phenotypes.
The growth cycle of a typical yeast culture in glucose
medium follows a distinct pattern. First, there is a phase of
logarithmic growth while cell density is relatively low and
glucose is fermented. When glucose is used up the cells un-
dergo a shift to respiratory metabolism and growth slows.
Finally yeast enter stationary phase—there is no further
growth, but they can survive for weeks without added nu-
trients, i.e., in water. Mutants lacking either SOD rapidly
lose viability after reaching stationary phase, and reactive
oxygen species originating from the mitochondria have
been shown to play a major role in the death of these
strains (24).
We previously studied Bcl-2 expressed in log phase
 
sod1
 
D
 
 yeast (deficient in CuZnSOD) and observed small
improvements in the oxygen-sensitive phenotype (19). Thus,
stationary phase in these strains, wherein yeast are dying
due to oxidative stress, seemed an ideal one in which to
study further the effects of Bcl-2 expression. While the
death we observed may not be apoptotic nor necessarily
due to any other form of programmed cell death, it is
clearly a reproducible death pattern, and the effects we
observe may therefore provide insight into the mechanism
of Bcl-2 action.
In the present paper, we describe our investigation of
the more dramatic effects of Bcl-2 expression on station-
ary phase yeast. The characteristic features of yeast in this
phase (use of respiration rather than glycolysis for energy,
lack of cell division, and prolonged survival time) make
cells in this phase a suitable model system for higher or-
ganisms. In addition, cell death can be studied in this sta-
tionary phase model system; it is thus particularly suitable
for studies of the effects of Bcl-2 expression since Bcl-2 ex-
erts its effects in mammalian cells by preventing death
rather than by promoting growth. Our goals for this study
were the following: (
 
a
 
) to determine if Bcl-2 functions as
an antioxidant in yeast; (
 
b
 
) to determine if Bcl-2 can block
cell death in a single-celled eukaryote; and (
 
c
 
) to define a
simple model system in which to study the mechanism of
action of Bcl-2. We report here our findings that Bcl-2 re-
verses growth and survival defects of yeast lacking super-
oxide dismutase and that it substantially improves survival
of wild-type 
 
S. cerevisiae
 
 under death-inducing conditions.
 
Materials and Methods
 
Yeast Strains
 
Strains of 
 
S. cerevisiae
 
 used in these studies are the following: EG103 (wild
type) (DBY746; 
 
MAT
 
a
 
 
 
leu2-3,112 his3
 
D
 
1 trp1-289 ura3-52 GAL
 
1
 
),
EG118 (
 
sod1
 
D
 
) (EG103 with 
 
sod1
 
D
 
A::URA3
 
), and EG133 (
 
sod1
 
D
 
sod2
 
D
 
)
(EG103 with 
 
sod1
 
D
 
A::URA3 sod2
 
D
 
::TRP1
 
) (9, 23). In these strains the
mutations in 
 
SOD1
 
 and 
 
SOD2
 
 are deletions of most of the coding region.
In all the experiments reported in this paper, these strains were trans-
formed with either plasmid pAD4, a multicopy yeast expression vector
carrying the 
 
LEU2
 
 selectable marker, or pAD4-
 
bcl-2
 
, the same vector car-
rying the human 
 
bcl-2
 
 gene under the transcriptional control of the strong
alcohol dehydrogenase (
 
ADH1
 
) promoter (19). Expression from this pro-
moter is high during log phase growth and decreases at stationary phase.
Transformations were carried out by the lithium acetate method (17). It
should be pointed out that, as observed in our previous study (24), 
 
sod1
 
mutants transformed with plasmids lost viability somewhat less rapidly
than untransformed mutants. This is a behavior that we have not yet ex-
plained, but which may be due to unavoidable selection for robustness
during the transformation, or to an effect of the 
 
LEU2
 
 marker, which was
present in all the plasmids. To test the latter possibility, the experiments
described herein were repeated with strains transformed with the plasmids
pBMT116 (vector control) and pBMT116-
 
bcl-2
 
 (carrying human 
 
bcl-2
 
cDNA), which are similar to the pAD4 plasmids, except that they contain
the 
 
TRP1
 
 selectable marker. Results with these plasmids (data not shown)
were similar to those reported in this paper using 
 
LEU2
 
 plasmids.
The expression of Bcl-2 was verified by Western analysis. A 25-
 
m
 
g sam-
ple of total cellular protein was run on a 15% SDS–polyacrylamide gel.
Purified human recombinant Bcl-2 was used as a control and Bcl-2 was de-
tected by anti–Bcl-2 antibody (cat. # 1624 989; Boehringer Mannheim Bio-
chemicals, Indianapolis, IN) using the Western-Light Plus Chemilumines-
cent Detection System (TROPIX, Inc., Bedford, MA). Bcl-2 antibody
(primary antibody) was diluted 1:80 and anti–rabbit alkaline phosphatase–
conjugated secondary antibody 1:10,000. In all cases where the 
 
bcl-2
 
 gene
was present (and in no cases where the gene was not present), protein that
reacted with the anti–Bcl-2 antibody was detected.
 
Media and Growth Conditions
 
Unless stated otherwise, all experiments in liquid media were performed
in synthetic dextrose complete media (SDC) with 2% glucose, and supple-
mented with amino acids, adenine and uracil as described (18) as well as a
fourfold excess of the supplements Trp, Leu, His, and uracil. Strains were
streaked from frozen stocks onto YPD (1% yeast extract, 2% peptone,
2% dextrose, 2% agar) plates. After 3 d of incubation, cells from a single
colony on the YPD plates were transferred to 3 ml of SDC overnight me-
dium lacking the appropriate supplement (Leu, ura, and/or Trp) to select
for plasmid-containing cells (
 
LEU
 
1
 
) with the correct SOD deletion
(
 
URA
 
1
 
 for 
 
sod1
 
D
 
 or 
 
TRP
 
1
 
 for 
 
sod2
 
D
 
). For normal oxygen (high aeration)
conditions, overnight cultures grown in selective media were inoculated at
an OD
 
600
 
 of 0.01 into flasks with a flask volume/medium volume ratio of 5:
1 and grown at 30
 
8
 
C, shaking at 220 rpm. Growth was followed by moni-
toring the turbidity at 600 nm (OD
 
600
 
). An OD
 
600
 
 of 1 is equivalent to 10
 
7
 
cells per ml. For long-term stationary phase cultures, after 72 h, the cells
were washed twice, resuspended in sterile distilled water, and incubation
with shaking was continued. Cell viability was measured by plating serial
dilutions of the yeast cultures onto YPD plates. Colonies formed were
counted after 2 d of incubation at 30
 
8
 
C. Plates from cell lines lacking
CuZnSOD were incubated in a low oxygen atmosphere generated using
CampyPaks (BBL Scientific, Cockeysville, MD). All experiments were re-
peated at least three times with duplicate samples.
For experiments in 100% oxygen, cells were grown to stationary phase
and on day 3 viability was measured as described above, except that plates
were incubated for 48 h in glass dessicators filled with 100% oxygen, fol-
lowed by incubation in air for the remainder of the time. The dessicator
containing the plates was filled by evacuating and refilling it with oxygen
two times. Alternatively, oxygen was gently blown in to the bottom of the
dessicator for 15 min, allowing gas to escape through a small hole in the
top. In either case, the container was then sealed and incubated at 30
 
8
 
C.
Oxygen was replenished after 24 h. Identical control platings were always
made and incubated in low oxygen (CampyPaks).
 
GSH Determination
 
Cells were grown as described above. At the desired time, 5 
 
3
 
 10
 
8
 
 cells
were pelleted at 3,000 
 
g
 
 and the supernatant was carefully removed. The
tubes were held on ice. 100 
 
m
 
l of 3.5% sulfosalicyclic acid and 100 
 
m
 
l of
glass beads (0.5 
 
m
 
m, acid washed and dried) were added. Cells were vor-
texed for 1 min and then placed on ice for 1 min. This vortexing/cooling
process was repeated six times. The samples were then centrifuged at
15,000 
 
g
 
 for 3 min. The acid soluble fraction was used to determine glu-
tathione concentration. Total glutathione was measured according to the
method of Tietze (36). Oxidized glutathione (GSSG) was measured using
the method of Griffith (11) in which 2-vinylpyridine was used to derivatize
the reduced form of glutathione. Standard curves used in this assay con-
tained all components used to derivatize the reduced form of the glu-
tathione.
 
Enzyme Activities and Metal Ion Levels
 
Crude cellular protein extracts were prepared by glass bead lysis as fol-
lows. Cells were suspended in lysis buffer at 4
 
8
 
C (50 mM Tris 7.2, 150 mM
NaCl, 5 mM EDTA, and 0.2 mM PMSF) with an equal volume of acid
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washed 0.5 mm glass beads, and vortexed for six to eight cycles of 30 s of
vortexing followed by 30 s of cooling. The mixture was then microfuged
for 2 min to remove the cellular debris and glass beads. The supernatant
was frozen until assayed. The catalase activity was determined spectro-
photometrically by monitoring the disappearance of hydrogen peroxide at
240 nm (25). SOD activity was determined by monitoring inhibition of the
autoxidation of 6-hydroxydopamine (14, 15). Protein concentration was
determined using the Bio Rad assay (Bio Rad Laboratories, Hercules,
CA), with bovine serum albumin as protein standard.
Copper and manganese were determined by atomic absorption spec-
trophotometry, using a Varian SpectrAA (Varian Instr. Business, San
Fernando, CA) equipped with graphite furnace. Whole cell samples were
digested in 3% HNO
 
3
 
 at 100
 
8
 
C overnight, and then diluted to 0.1% HNO
 
3
 
for analysis. Alternatively soluble protein extracts were made to 0.1%
HNO
 
3
 
 and incubated overnight before analysis.
 
Mutation Frequencies
 
Mutation frequency was estimated by determining the number of cells
able to form colonies on SDC plates lacking arginine and containing 60
 
m
 
g/ml canavanine. (Resistance to canavanine, an arginine analogue, arises
when mutations in the arginine permease occur.) Approximately 100 mil-
lion cells were removed from cultures after 72 h of incubation and plated
on canavanine plates. Colonies were counted after 4 d. Mutation frequen-
cies are reported as mutants per 10
 
6
 
 viable cells. Three separate experi-
ments with duplicate platings of duplicate samples were performed.
 
Results
 
Bcl-2 Reversed Viability Defects of sod1
 
D
 
 and 
sod1
 
D
 
sod2
 
D
 
 Mutants
 
To determine whether human Bcl-2 could overcome cell
death associated with oxidative stress, we expressed Bcl-2
in strains lacking either or both SODs. In the paradigm
used here (24), cells were grown to saturation in SDC me-
dium. At 72 h, the cells were washed, resuspended in wa-
ter, and the incubation continued. Under this treatment,
strains lacking either SOD are known to lose viability rap-
idly (24), beginning at entrance into stationary phase,
while wild-type cells survive up to 2 mo.
In the present study, 
 
sod1
 
D
 
 and 
 
sod1
 
D
 
sod2
 
D
 
 mutants
transformed with either the multicopy plasmid pAD4–
 
bcl-2
 
or the vector control pAD4, were tested for survival. Early
in the culture, when growth was logarithmic (early log
phase, 
 
,
 
2 
 
3
 
 10
 
7
 
 cells/ml) Bcl-2 had little effect on the via-
bility (Fig. 1). At late log phase (
 
z
 
6 
 
3
 
 10
 
7
 
 cells/ml, gener-
ally reached after 10–15 h of growth), differences began to
be apparent. By the time stationary phase was reached at
24 h (10–13 
 
3
 
 10
 
7
 
 cells/ml, no further growth), differences
were quite obvious. At 24 h, 
 
sod1
 
D
 
 and 
 
sod1
 
D
 
sod2
 
D
 
strains expressing Bcl-2 maintained their viability, while
the viability of strains carrying plasmid controls was mark-
edly reduced (Fig. 1). Over a culture period of 26 d, viabil-
ity for all strains continued to decrease and the strain ex-
pressing Bcl-2 continued to show a much higher survival
rate than the control. Table I (
 
first two columns
 
) summa-
rizes the survival of the 
 
sod1
 
D
 
 and 
 
sod1
 
D
 
sod2
 
D
 
 strains
with or without Bcl-2 expression at 26 d. Because of the
large difference in viability already evident at day 1 (Fig. 1)
we also show the data normalized to the viability on day 1
(Table I, 
 
last two columns
 
). For the 
 
sod1
 
D
 
 strain, the dif-
ference was statistically significant (
 
P
 
 
 
, 
 
0.01 by the two-
sided 
 
t
 
 test) in both cases (raw data as well as normalized).
The difference for the sod1Dsod2D strain was not statisti-
cally significant, although the trend was always the same as
for the single sod1D mutant. Nevertheless, the major effect
of Bcl-2 expression on survival in these experiments
clearly occurred at the time of entry into stationary phase,
rather than in the later stages.
Bcl-2 Improved Survival of sod1D Mutants in
100% Oxygen
Somewhat surprisingly, wild-type yeast with or without
Bcl-2 expression grew well in 100% oxygen, exhibiting 80–
100% viability relative to growth in air (data not shown).
On the other hand, yeast lacking CuZnSOD and/or MnSOD
were quite sensitive to 100% oxygen and were unable to
form colonies under these conditions. To test the effect of
Bcl-2 expression on the growth of sod1D, sod2D, and
sod1Dsod2D mutants under this intense oxidative stress,
Figure 1. Bcl-2 reversed stationary phase viability loss in strains
lacking one or both SODs. Percent viability of sod1D (EG118)
and sod1Dsod2D (EG133) strains with or without Bcl-2 expres-
sion at different stages of growth. Data are reported as percent vi-
able cells, or colony forming units (live cells), per total cells (live
and dead cells). Total cell number was determined by optical
density (OD600) and confirmed by hemocytometer counting. Dif-
ferences between control and Bcl-2–expressing strains at 24 h are
significant (P , 0.01). (white bars) sod1D; (gray bars) sod1D-
sod2D; (crosshatched pattern) strains expressing Bcl-2; (no pat-
tern) strains harboring plasmid vector (pAD4).
Table I. Long Term Viability of Strains Expressing Bcl-2
Viable cells/ml (3 106) on
day 26
Data normalized to
viability on day 1 (%)
Plasmid pAD4 pAD4-bcl-2 pAD4 pAD4-bcl-2
Host Strain
Wild-type 49.5 (0.7) 43.0 (4.2) 76 (1.1) 64 (6.2)
sod1D 0.77 (1.07) 10.9 (3.4)* 2.5 (3.4) 20 (6.4)*
sod1Dsod2D 0.16 (0.17) 0.65 (0.07) 0.5 (0.6) 1.2 (0.1)
Cultures of wild-type (EG103) sod1D (EG118) and sod1Dsod2D (EG133) strains with
and without Bcl-2 expression were grown, switched to water on day 3, and tested for
viability at intervals, as described in Materials and Methods. The table shows the via-
bility measured on day 26. Standard deviations are in parentheses. In the first two col-
umns, total viable cells are reported. In last two columns, the same data are shown as a
percent of the number of viable cells in the same culture on day 1 to correct for the
loss of viability which occurred immediately upon entry into stationary phase. An as-
terisk marks data sets where the difference between with and without Bcl-2 was statis-
tically significantly (P , 0.01).
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we tested the ability of these strains to survive a 48 h ex-
posure to 100% oxygen. As shown in Fig. 2, expression of
Bcl-2 in SOD-deficient cells substantially improved their
ability to form colonies after incubation in 100% oxygen.
The effect was particularly pronounced for the sod1D sin-
gle mutant, but was also evident for the sod2D single mu-
tant and the double mutant.
Effects of Bcl-2 Are Not Due to Altered Copper or 
Manganese Metabolism
Culotta and co-workers (21–23) have recently identified
several mutations that partially “rescue” the sod1D sod2D
strain, and they showed that each of these mutations al-
tered copper or manganese metabolism in some way. One
of these, the pmr1 mutation, exerted its effects by increas-
ing cellular manganese accumulation. (High intracellular
manganese was previously shown to rescue sod1D mu-
tants, probably by its own dismutase activity [2].) A side
effect of the pmr1 mutation is an increased sensitivity to
abnormally high manganese levels in the medium (21). We
reasoned that, if Bcl-2 exerted its effects by a mechanism
similar to that of pmr1, we should see increased sensitivity
to manganese and increased manganese accumulation in
strains expressing Bcl-2. In fact, we saw the opposite, ex-
pression of Bcl-2 in strains lacking SOD led to decreased
sensitivity to elevated manganese levels as measured by
cell survival (Fig. 3 A) and decreased manganese accumu-
lation as measured by atomic absorption (Fig. 3 B). In other
words, Bcl-2 expression caused the sod1D and sod1Dsod2D
strains to exhibit a more wild-type–like phenotype.
Culotta and co-workers also observed that a mutation in
the yeast BSD2 gene bypassed the growth requirement for
SOD by altering copper homeostasis in a manner seem-
ingly analogous to the pmr1 mutation. In this case, cells
became hypersensitive to elevated copper concentrations
(22). We tested sod1D and sod1Dsod2D strains expressing
Bcl-2 for copper sensitivity and saw a slight, although not
statistically significant, decrease in sensitivity in the Bcl-2
expressors (data not shown). This decrease came instead
of the marked increase we would have expected if Bcl-2
were working through a mechanism like that of bsd2. We
conclude that, unlike other suppressors of the sod1D phe-
notype, Bcl-2 does not work via effects on copper or man-
ganese accumulation.
Figure 2.  Bcl-2 expression allowed sod1D mutants to form colo-
nies in 100% oxygen. sod1D (EG118), sod2D (EG110), and
sod1Dsod2D (EG133) cells harboring pAD4–bcl-2 (crosshatched
bars) or pAD4 (open bars), were grown to stationary phase and
equal numbers of cells were plated on selective plates (SD–leu)
and incubated in low aeration (CampyPaks) for 3 d, or in an at-
mosphere of 100% oxygen for 48 h followed by incubation in air.
(Oxygen was replenished after 24 h.) Viability was recorded
when colonies became big enough to count—at day 3 (EG118) or
day 4 (EG110 and EG133)—and is reported as a percentage of
the viability of the same strain in low aeration (relative viability).
The experiment was performed with similar results at least four
times for each strain, with two separate samples in each experi-
ment. A representative experiment is shown.
Figure 3. Bcl-2 expression and Mn metabolism. (A) Wild-type
(EG103), sod1D (EG118), and sod1Dsod2D (EG133) cells trans-
formed with pAD4 or pAD4–bcl-2 were inoculated at 106 cells/ml
in SD–leu medium with or without 5 mM MnSO4 added, and in-
cubated at 308C and 220 rpm. OD600 was measured at 48 h. Ex-
periments were performed three times with duplicate samples
from two separate transformations. Results are reported relative
to growth of wild type without Bcl-2 measured on the same day.
(B) The same strains were analyzed for manganese accumulation
by atomic absorption at stationary phase (after 3 d of incubation
in SDC medium with normal levels of manganese). Experiments
were repeated three times. Results are reported as percent of the
manganese levels of the wild-type strain (lacking Bcl-2) measured
on the same day.
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Indices of Antioxidant Protection in Cells
Expressing Bcl-2
To determine if Bcl-2 had a direct effect on the status of
other antioxidant proteins in yeast, we measured catalase
activity in both wild-type and sod1D mutant cells express-
ing Bcl-2 (Fig. 4). Yeast has two catalases (Catalase A and
Catalase T), but only the cytoplasmic Catalase T is ex-
pressed under our conditions. Catalase A is peroxisomal
and only expressed under special conditions (8). We ob-
served an increase in catalase activity for wild-type cells
expressing Bcl-2 relative to vector-transformed controls.
The sod1D mutant had a lower level of catalase than wild
type. Bcl-2 expression caused an increase in catalase activ-
ity, but the activity was still lower than that of the wild-
type strain (Fig. 4).
We also monitored levels of reduced and oxidized glu-
tathione (GSH and GSSG, respectively) in wild-type cells
with or without expression of Bcl-2. Total glutathione
(GSH 1 GSSG) levels were unchanged by Bcl-2 expres-
sion, but the GSH:GSSG ratio increased from 85:1 for the
vector-transformed control to 105:1 for the Bcl-2 expres-
sor, indicating a slightly more reducing condition in the
cells expressing Bcl-2. This result was significant to the
P , 0.1 level.
Mutation Frequencies Increased in sod1D and
sod1Dsod2D Mutants Compared to Wild Type, but 
Decreased in Yeast Expressing Bcl-2
Steinman reported that expression of Bcl-2 in Escherichia
coli led to increased catalase expression and a higher mu-
tation rate, and he therefore proposed a pro-oxidant mech-
anism for Bcl-2 in this system (33). To determine whether
a similar phenomenon occurred in yeast expressing Bcl-2,
we measured mutation frequencies, using forward muta-
tion to canavanine resistance. As expected based on ear-
lier work (9), mutation frequencies were clearly higher in
sod1D and sod1Dsod2D mutants than in the wild-type pa-
rental strain. However, in all three cell lines, Bcl-2 expres-
sion decreased mutation frequencies (Table II). This result
is consistent with an antioxidant activity for Bcl-2, since
oxidative damage is believed to be the cause of much
spontaneous mutation and is almost certain to be the
cause of the excess spontaneous mutation found in strains
lacking CuZnSOD.
Bcl-2 Prolonged Wild-Type Yeast Survival in
Spent Medium
We recently observed that yeast cells left in expired syn-
thetic glucose medium (SDC), but not in rich medium
(YPD) or water, lost viability quickly (Longo, V.D., P. Mor-
cos, T.E. Johnson, E.B. Gralla, and J.S. Valentine, manu-
script submitted for publication). To determine whether
Bcl-2 could affect this type of cell death, we studied sur-
vival in water and in expired SDC medium of wild-type
yeast expressing Bcl-2. Wild-type yeast left in complete
glucose medium (SDC) rapidly lost viability beginning at
day 5. The viability loss was significantly delayed by ex-
pression of Bcl-2 such that there was a five- to sixfold dif-
ference in the number of survivors by day 10 (Fig. 5). To
be sure that the viability loss was not caused by the nutri-
tional auxotrophies of the EG103 wild-type strain, survival
in spent medium was also measured for the prototrophic
strains D27310b, which also lost viability prematurely
(data not shown). By contrast, no effect of Bcl-2 was seen
on survival of wild-type yeast under conditions optimal for
stationary phase survival, i.e., switched to water at day 3,
probably because survival was already very high (Fig. 5).
Discussion
The yeast sod1D and sod1D sod2D strains provide a simple
model system for studies of the properties of Bcl-2. The
presence of Bcl-2 prevented short-term death of both
yeast sod1D and sod1D sod2D mutants at the point of entry
into stationary phase (Fig. 1). In addition, it improved, al-
though less dramatically, their long-term survival (Table II).
Furthermore, Bcl-2 enabled sod1D, but not sod1Dsod2D,
mutants to grow in 100% oxygen (Fig. 2) and increased in-
Figure 4. Bcl-2 expression increased catalase activity in station-
ary phase yeast. Protein extracts were prepared from wild-type
and sod1D cells transformed with pAD4 or pAD4–bcl-2 and
grown 72 h (to stationary phase). Catalase activity was measured
as described in Materials and Methods. Results are the average of
four experiments and are reported as percent of wild-type activ-
ity; error bars represent standard deviation. The asterisks indi-
cate data sets that are significantly different (P , 0.05 by the two-
sided t test). The difference between wild-type and either sod1D
strain was also statistically significant. Specific activity for wild
type was 770 U/mg protein.
Table II. Mutation Rates
Strain Experiment 1 Experiment 2 Experiment 3
Average
(SD)
wt/pAD4 2.8 5.0 3.3 3.7 (1.1)
wt/pAD4-bcl-2 2.2 3.3 2.1 2.5 (0.7)
sod1D/pAD4 6.5 6.3 6.5 6.4 (0.1)
sod1D/pAD4-bcl-2 3.3 4.3 5.0 4.2 (0.8)
sod1Dsod2D/pAD4 7.6 11.3 8.5 9.1 (1.9)
sod1Dsod2D/pAD4-bcl-2 3.7 7.0 6.3 5.7 (1.7)
Cells were grown for 72 h and then plated on plates containing canavanine. Mutation
to canavanine resistance is expressed as resistant cells per 106 viable cells. Three sepa-
rate experiments were performed and are reported separately. The average and stan-
dard deviation are also reported.
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dicators of antioxidant defense, i.e., catalase (Fig. 4) and
reduced glutathione. These results confirm an antioxidant
property for Bcl-2 and suggest that it functions in this re-
gard by acting on basic intracellular mechanisms present
in all eukaryotes (in human cells as well as in yeast).
Mechanisms of oxidative stress and antioxidant defenses
in vivo are intimately connected with metal metabolism.
Most pathways that have been proposed for generation of
significant fluxes of reactive oxygen species in vivo involve
participation of redox active metal ion catalysts (usually
copper or iron ions). Defensive mechanisms also often in-
volve metal ions, e.g., superoxide dismutase and catalase
are metalloenzymes. Studies on sod1D yeast have demon-
strated the importance of metal ions in oxidative stress re-
sistance. First, high levels of extracellular manganese ion
rescued sod1D strains, apparently because excess manga-
nese accumulated in the cytoplasm and was able to func-
tion as a weak dismutase (2). In addition, sod1D strains
have been shown to be partially rescued by excess copper
in the medium. This rescue depended upon intracellular
binding of the metal by the yeast copper metallothionein
protein (34), rather than on a “free” metal ion as is postu-
lated for manganese, but is otherwise similar.
Thus far, all mutations identified that reverse growth de-
fects of sod1D and sod1D sod2D yeast appear to cause ac-
cumulation of manganese or copper in the cytosol. If Bcl-2
were involved in the accumulation of manganese or cop-
per, as are the products of the PMR1 and BSD2 genes, re-
spectively (21, 22), we would have expected a higher sensi-
tivity to elevated concentrations of these metal ions in
cells expressing the oncoprotein. We found instead that
Bcl-2 improves the growth of sod1D and sod1D sod2D mu-
tants in the presence of both metals but especially manga-
nese (Fig. 3), indicating that it works in another fashion.
We have not yet determined whether this improvement is
due to a general decrease of the oxidative stress in the cells
or to a direct involvement of Bcl-2 in manganese homeo-
stasis or subcellular distribution.
Mammalian neural cells expressing Bcl-2 have recently
been shown to contain increased concentrations of glu-
tathione (5, 19). The expression of Bcl-2 in E. coli was
shown to induce catalase expression without exposure to
exogenous hydrogen peroxide. It also led to increased mu-
tation rates, leading the author to conclude that this onco-
protein functions as a prooxidant (33). In yeast, we also
observed an increase in catalase activity in strains express-
ing Bcl-2 (Fig. 4), but the spontaneous mutation frequency
was reduced by Bcl-2 expression (Table II). In addition,
wild-type yeast expressing Bcl-2 had slightly higher GSH/
GSSG ratios than wild-type controls, although no differ-
ence in total glutathione was observed. Taken together,
these data argue against a prooxidant effect of this onco-
protein in yeast and support a role for Bcl-2 in promoting
antioxidant defenses.
We observed that wild-type yeast kept in expired SDC
medium (not switched to water) during stationary phase
lost viability rapidly. While the death of sod1D and sod1D-
sod2D strains is known to be oxidative (24) it is not clear to
what to attribute the death of wild-type cells in expired
medium. The death of wild-type cells in expired medium
was delayed by the expression of human Bcl-2 (Fig. 5).
The precipitous viability loss we observed for yeast in ex-
pired minimal medium was quite surprising, especially in
view of the fact that yeast transferred to water show no
such dramatic viability loss and instead survive for months.
A possible explanation is based on the assumption that
yeast are likely to encounter a nutrient-depleted environ-
ment quite often in the wild and therefore might be ex-
pected to recognize and respond to such a condition. It is
thus possible that death could be an evolved response to
such a situation. One’s first notion is that in a unicellular
organism such as yeast, each individual cell competes
against all others. However, this approach may not be the
most effective for maintenance of the species. Yeast grow
in colonies that are generally isogenic, so survival of the
genes of a single colony is guaranteed even if only a few
organisms survive. The cell death we observed in expired
medium could be explained by a specific cell suicide pro-
gram, evolved to kill most members of a colony so that a
few better-adapted individuals could survive and grow on
the limited nutrients. This putative death program would
increase the chance of survival of the species. The better
adaptation of the lucky individual(s) that survived could
be due either to mutations (leading to natural selection) or
simply to random variation in the micro-environment. (Note
that such a suicide response would not be expected to
occur in pure water. Since there are no nutrients to be
shared, the best response is for each cell to last as long as
possible.)
Ras2 is one of two yeast Ras proteins that play roles in
growth control and have structural and functional homol-
ogy to the ras family of mammalian proto-oncogenes. In
yeast, Ras is coupled to a signal cascade that involves in-
tracellular cAMP and is sensitive to nutritional status (7,
35). In another study, we found that the viability loss of
yeast in expired minimal medium was prevented by a null
mutation in ras2, suggesting that Ras2 is involved in a cell
death pathway (Longo, V.D., P. Morcos, T.E. Johnson,
Figure 5. Bcl-2 delayed viability loss in wild-type yeast. Wild-
type yeast (EG103) transformed with pAD4 or pAD4–bcl-2 were
grown in complete glucose medium (SDC), and left in the me-
dium (h, j), or switched to water at 72 h (s, d). Viability was
assayed by plating on YPD plates at the indicated times. The ex-
periment was repeated four times with similar results. A repre-
sentative experiment is shown. Note that the viability is reported
on a log scale. pAD4 transformed (j, d); pAD4–bcl-2 trans-
formed (h, s).
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E.B. Gralla, and J.S. Valentine, manuscript submitted for
publication). Interestingly, extracellular cAMP and starva-
tion are involved in initiating the cell death program of
stalk cells in the developmental cycle of the primitive eu-
karyote Dictyostelium (4). In human cells, Bcl-2 has been
shown to co-precipitate with both R-Ras and p21-Ras (3,
6) both of which are highly homologous to yeast Ras2
(7). These observations raise the possibility that Bcl-2 may
prevent cell death in yeast by acting through the Ras
pathway.
Evidence is slowly accumulating that some lower eu-
karyotes, even unicellular ones, exhibit programmed cell
death, which, however, may or may not share the morpho-
logical features that define apoptotic cell death (1). For ex-
ample, a cell death program was demonstrated in E. coli,
consisting of a plasmid-encoded DNA restriction/modifi-
cation system that caused DNA cuts but not other typical
apoptotic morphologies (28). Cell death during stalk for-
mation in Dictyostelium followed a distinct program that
included chromatin condensation, but not DNA fragmen-
tation (4). Other, nonapoptotic forms of PCD may occur
in higher eukaryotes as well. For example, none of the fea-
tures characteristic of apoptosis were observed in the PCD
of intersegmental muscle of the moth Manduca sexta at
the end of metamorphosis (31).
The results presented here are consistent with the pres-
ence of a programmed cell death pathway in yeast, but
they are equally consistent with an antioxidant role for
Bcl-2 which could be acting on pathways or proteins that
promote compensatory antioxidant defenses in sod null
mutants as well as wild-type cells under certain circum-
stances. Our searches of the yeast whole genome database
did not reveal the presence of homologues of pro-apop-
totic proteins such as ICE or CED-3, suggesting that a pro-
grammed cell death in yeast, if it does indeed exist, may
not involve the proteins and mechanisms that cause apop-
tosis in higher eukaryotes. No Bcl-2 homologues with high
identity were found either, but we cannot exclude the pos-
sibility that functional rather than sequence homologues
of Bcl-2 may be present in yeast, or that bcl-2 is a relatively
new feature of apoptosis, added later in evolution.
There are only a few reports in the literature examining
members of the bcl-2 gene family expressed in yeast (10,
13, 30). These papers are based on the finding that expres-
sion of Bax, a cell death–inducing Bcl-2 family member, is
toxic to yeast. Using the two-hybrid system, Reed and co-
workers (13, 30) showed that this Bax-induced cell death
was inhibited by co-expression of Bcl-2 and some Bcl-2
homologues which are known to interact physically with
Bax. However, since expression of foreign proteins fairly
frequently causes cell death, it is not clear in these studies
whether the death observed is a specific triggered cell
death pathway or simply the result of a non-specific toxic-
ity. If the latter is the case, then rescue by Bcl-2 could be
explained simply as a case of Bcl-2/Bax dimerization mask-
ing the toxicity. Our results demonstrate an antideath ac-
tivity for Bcl-2 in yeast in the absence of Bax, increasing
the possibility that a real cell death program is being ob-
served.
Recent work (10) using a similar system, demonstrated
that Bax-related growth inhibition could be experimen-
tally separated from cellular death in S. cerevisiae and that
the presence of functional mitochondria was necessary for
cell death to occur. These results make it appear more
likely that Bax is acting on an endogenous system. In our
work, both the oxidative stress-related death of sod1D and
sod1D sod2D mutants in stationary phase and the death of
wild-type cells in expired minimal medium occurred with-
out introduction of any foreign genes, i.e., they are natu-
rally occurring processes. That Bcl-2 is able to prevent
both kinds of death is therefore strong evidence that it is
acting on, or in concert with, an endogenous pathway that
already exists in yeast.
In conclusion, our results demonstrate that Bcl-2 can
provide antioxidant protection in yeast and that it can de-
lay natural death in two separate paradigms. The fact that
Bcl-2 exerts an antioxidant-type protective effect in yeast
is evidence supporting the centrality of this role. However,
it is important to stress that the mechanism by which the
antioxidant protection occurs and the connection between
the antideath and antioxidant actions of Bcl-2 in our sys-
tem, as well as in mammalian cells, remains unknown.
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